Atypical chronic myeloid leukemia achieving good response with azacitidine
We report the case of a aCML patient successfully treated with AZA. A 66-year-old man with no remarkable medical history was admitted to our hospital because of leukocytosis. We diagnosed his disease as aCML and administered hydroxyurea (HU) and AZA. After four courses of AZA, his blood cell values improved, and he no longer needed transfusions and was able to stop HU. He continued receiving AZA without any severe complications. This is the first report that AZA is effective for the treatment of aCML.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Atsushi Marumo Taro Mizuki Sakae Tanosaki Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Hospitals | India Health | Leukemia | Stem Cell Therapy | Stem Cells | Transplants